当前位置: 首页 > 详情页

Vascular Endothelial Growth Factor and Erythropoietin Show Different Expression Patterns in the Early and Late Hypoxia Preconditioning Phases and May Correlate with DNA Methylation Status in the Mouse Hippocampus

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Laboratory Medicine, Center for Translational Medicine, the Third People’s Hospital of Longgang District, Shenzhen, China. [2]Inner Mongolia Key Laboratory of Hypoxic Translational Medicine, Baotou Medical College of Neuroscience Institute, Baotou Medical College, Inner Mongolia, China. [3]Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China. [4]Department of Neurology, The Second Affiliated Hospital of Shandong First Medical University, Shandong, China. [5]Department of Oral and Maxillofacial Surgery, University of California San Francisco, San Francisco, California, USA. [6]Department of Neurosurgery, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia, China. [7]Joint Laboratory of South China Hospital Affiliated to Shenzhen University and Third People’s Hospital of Longgang District, Shenzhen University, Shenzhen, China.
出处:
ISSN:

关键词: DNA methyltransferase erythropoietin hypoxia preconditioning vascular endothelial growth factor

摘要:
Liu, Na, Yanbo Zhang, Pu Zhang, Kerui Gong, Chunyang Zhang, Kai Sun, and Guo Shao. Vascular endothelial growth factor and erythropoietin show different expression patterns in the early and late hypoxia preconditioning phases and may correlate with DNA methylation status in the mouse hippocampus. High Alt Med Biol. 00:000-000, 2022.Background: Vascular endothelial growth factor (VEGF) and erythropoietin (EPO) have been proven to participate in neuroprotection induced by hypoxia preconditioning (HPC), and they can be regulated by hypoxia-inducible factor 1 (HIF-1). It has been reported that DNA methylation can affect VEGF and EPO expression. This study aimed to explore the expression of VEGF and EPO in the early phase and late phase of HPC and whether their expression was affected by DNA methylation.Method: Acute repeated HPC mice were used as the animal model, and detection of molecular changes was performed immediately (early phase) and 1 day (late phase) after HPC treatment. The mRNA and protein expression levels of VEGF, EPO, and DNA methyltransferases (DNMTs) in the hippocampi were measured by real-time polymerase chain reaction and western blotting, respectively. The activity of DNMTs and global methylation levels were analyzed by enzyme-linked immunosorbent assay. DNA methylation levels of VEGF and EPO promoters, which were catalyzed by DNMTs, were determined by bisulfite-modified DNA sequencing.Results: The expression of VEGF was increased in the early phase and late phase of HPC (p < 0.05), whereas the expression of EPO was unchanged in the early phase (p > 0.05) of HPC and was increased in the late phase (p < 0.05). VEGF and EPO expression were negatively correlated with the DNA methylation levels of their promoters. DNMT3A and DNMT3B were decreased in the early phase and late phase (p < 0.05), whereas DNMT1 was unchanged in the early phase and late phase (p > 0.05).Conclusions: Our data demonstrated that DNMTs affect VEGF and EPO expression by regulating the DNA methylation levels of the promoters of VEGF and EPO.

基金:

基金编号: 81660307 82060337 LGKCYLWS2021000033 JCYJ20220531092412028

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 生物物理 4 区 公共卫生、环境卫生与职业卫生 4 区 运动科学
最新[2023]版:
大类 | 4 区 医学
小类 | 3 区 生物物理 4 区 公共卫生、环境卫生与职业卫生 4 区 运动科学
JCR分区:
出版当年[2020]版:
Q3 SPORT SCIENCES Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Q4 BIOPHYSICS
最新[2023]版:
Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Q3 SPORT SCIENCES Q4 BIOPHYSICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Department of Laboratory Medicine, Center for Translational Medicine, the Third People’s Hospital of Longgang District, Shenzhen, China. [2]Inner Mongolia Key Laboratory of Hypoxic Translational Medicine, Baotou Medical College of Neuroscience Institute, Baotou Medical College, Inner Mongolia, China. [3]Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
通讯作者:
通讯机构: [1]Department of Laboratory Medicine, Center for Translational Medicine, the Third People’s Hospital of Longgang District, Shenzhen, China. [2]Inner Mongolia Key Laboratory of Hypoxic Translational Medicine, Baotou Medical College of Neuroscience Institute, Baotou Medical College, Inner Mongolia, China. [3]Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China. [6]Department of Neurosurgery, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia, China. [7]Joint Laboratory of South China Hospital Affiliated to Shenzhen University and Third People’s Hospital of Longgang District, Shenzhen University, Shenzhen, China. [*1]Department of Neurosurgery The First Affiliated Hospital of Baotou Medical College Inner Mongolia 014010 China [*2]Department of Laboratory Medicine Center for Translational Medicine the Third People’s Hospital of Longgang District Shenzhen 518112 China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院